Qube Research & Technologies Ltd - TALARIS THERAPEUTICS INC ownership

TALARIS THERAPEUTICS INC's ticker is TALS and the CUSIP is 87410C104. A total of 50 filers reported holding TALARIS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of TALARIS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$28,319
-72.8%
10,078
-70.6%
0.00%
Q2 2023$104,18134,2700.00%
Other shareholders
TALARIS THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Aisling Capital Management LP 682,923$10,032,0001.61%
SECTORAL ASSET MANAGEMENT INC 711,000$10,445,0000.84%
Logos Global Management LP 507,923$7,461,0000.63%
Artal Group S.A. 2,064,262$30,324,0000.62%
Cormorant Asset Management, LP 1,215,847$17,264,0000.59%
Eventide Asset Management 1,561,092$22,411,0000.30%
Blackstone Inc. 8,089,315$118,832,0000.27%
Avidity Partners Management LP 436,363$6,410,0000.17%
VIKING GLOBAL INVESTORS LP 3,289,617$48,324,0000.15%
HHLR ADVISORS, LTD. 853,344$12,536,0000.13%
View complete list of TALARIS THERAPEUTICS INC shareholders